Our new web platform, "collectio," provides an extensive database covering 3,600 biopharma companies worldwide, presenting in-depth data on pipelines, modalities, and cutting-edge technologies. It empowers the researcher's information-gathering activities and boosts their ideas.
A short report is published on Nikkei Biotech. The article analyzes emerging biotechs leveraging AI technology for drug discovery of modern biologics modalities, such as antibodies, oligonucleotides, and gene therapy.
Diversifying modalities of AI drug discovery, beyond small molecule compounds
We posted short repots on Nikkei Biotech. It provides pipeline analysis by biotech listing year to analyze the trends and changes in modalities, and investigated unique drug discovery approaches of five biotechs who have a program with “unusual” modalities.
1) Biotechs to IPO Quicker, More Oncology Focused
2) Featured Biotechs Developing Unique Modalities
Thanks to our valued clients, we've provided Advisory Service and Drug Discovery R&D Support to 10 clients, totally 50 projects. We will continue to make efforts to improve our services further.
The head office has moved. When you visit Tokyo Nihonbashi, please stop by.